Hector Ortega

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. doi Association of CHI3L1 in African-Americans with prior history of asthma exacerbations and stress
    Hector Ortega
    Respiratory Medcines Development Center, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    J Asthma 50:7-13. 2013
  2. doi Characterization of asthma exacerbations in primary care using cluster analysis
    Hector Ortega
    Respiratory and Immuno inflammation, Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
    J Asthma 49:158-69. 2012
  3. doi Genetic analysis of asthma exacerbations
    Wayne H Anderson
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Ann Allergy Asthma Immunol 110:416-422.e2. 2013

Collaborators

  • Wayne H Anderson
  • Beena T Koshy
  • Lynn D Condreay
  • Lingkang Huang
  • Michael Mosteller
  • Sandra W Stinnett

Detail Information

Publications3

  1. doi Association of CHI3L1 in African-Americans with prior history of asthma exacerbations and stress
    Hector Ortega
    Respiratory Medcines Development Center, GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    J Asthma 50:7-13. 2013
    ..Asthma exacerbations are influenced by multiple factors including environmental exposures, psychosocial interactions, and genetic variations...
  2. doi Characterization of asthma exacerbations in primary care using cluster analysis
    Hector Ortega
    Respiratory and Immuno inflammation, Medicines Development Center, GlaxoSmithKline, Research Triangle Park, NC 27709 3398, USA
    J Asthma 49:158-69. 2012
    ..Patients with a history of asthma exacerbations are at a higher risk for future episodes of severe asthma exacerbations. Characterization of asthma phenotypes could help improve asthma management, including reducing exacerbations...
  3. doi Genetic analysis of asthma exacerbations
    Wayne H Anderson
    GlaxoSmithKline, Research Triangle Park, NC 27709, USA
    Ann Allergy Asthma Immunol 110:416-422.e2. 2013
    ..Identifying genetic markers of susceptibility to exacerbations may improve patient management, decrease morbidity, and lead to drug development...